Overall, this study identifies [<sup>68</sup>Ga]-Ga-SK01014 as a promising NTSR1-targeted imaging agent with improved renal clearance and provides insight into the balance between stability and receptor-driven tumor uptake, guiding the future design of neurotensin-based theranostic agents. Here, NTSR1 is linked to neoplasm.